(Q39202020)

English

Accelerometer-based quantitative analysis of axial nocturnal movements differentiates patients with Parkinson's disease, but not high-risk individuals, from controls

scientific article published on 28 April 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Accelerometer-based quantitative analysis of axial nocturnal movements differentiates patients with Parkinson's disease, but not high-risk individuals, from controls (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Inga Liepelt-Scarfone

11

object named as

Inga Liepelt-Scarfone

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

7

object named as

Bastiaan R Bloem

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Sebastiaan Overeem

10

object named as

Sebastiaan Overeem

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

9

object named as

Daniela Berg

2 references

Europe PubMed Central

PubMed publication ID

9 September 2017

ORCID Public Data File 2021

Walter Maetzler

2

object named as

Walter Maetzler

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

author name string

Maartje Louter

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Jos Prinzen

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Rob C van Lummel

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Markus Hobert

5

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Johan B A M Arends

6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Johannes Streffer

8

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

language of work or name

0 references

publication date

28 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Journal of Neurology, Neurosurgery and Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

86

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

32-37

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

The patients' perception of prodromal symptoms before the initial diagnosis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Association of olfactory dysfunction with risk for future Parkinson's disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Impaired trunk stability in individuals at high risk for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Subjective complaints precede Parkinson disease: the rotterdam study

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Perceived imbalance and risk of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Motor signs in the prodromal phase of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Transcranial brain parenchyma sonography in movement disorders: state of the art.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Defining at-risk populations for Parkinson's disease: lessons from ongoing studies

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Actigraphic evidence for night-time hyperkinesia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Sleep movements and associated autonomic nervous activities in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Evaluation of progression markers in the premotor phase of Parkinson's disease: the progression markers in the premotor phase study

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Screening of olfactory function with a four-minute odor identification test: reliability, normative data, and investigations in patients with olfactory loss

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Risk of Parkinson's disease among first-degree relatives: A community-based study

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

The REM sleep behavior disorder screening questionnaire--a new diagnostic instrument

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Restless legs syndrome in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Validation of the DynaPort MiniMod during sleep: a pilot study

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Gait alterations in healthy carriers of the LRRK2 G2019S mutation.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Gait variability: methods, modeling and meaning

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Excessive daytime sleepiness and subsequent development of Parkinson disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306851

21 January 2018

Identifiers

10.1136/JNNP-2013-306851

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39202020&oldid=2174842380"